Shortage reports
Actual shortage:
257 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3300 (92%)
3571
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-QUETIAPINE | 300MG | TABLET | Resolved | 2017-11-01 | 2018-01-13 | 27735 |
| APO-QUETIAPINE | 300MG | TABLET | Resolved | 2021-05-14 | 2021-06-07 | 139419 |
| APO-QUETIAPINE | 100MG | TABLET | Resolved | 2020-08-12 | 2020-09-04 | 122077 |
| APO-QUETIAPINE | 100MG | TABLET | Resolved | 2017-10-18 | 2018-01-13 | 26195 |
| APO-QUETIAPINE | 25MG | TABLET | Resolved | 2017-09-27 | 2018-01-03 | 23635 |
| APO-QUETIAPINE | 200MG | TABLET | Resolved | 2020-08-19 | 2021-05-31 | 122495 |
| APO-QUETIAPINE | 300MG | TABLET | Actual shortage | 2021-08-27 | 2021-08-27 | 144779 |
| APO-QUETIAPINE | 100MG | TABLET | Resolved | 2020-08-19 | 2020-09-04 | 122492 |
| APO-QUETIAPINE | 100MG | TABLET | Resolved | 2021-04-05 | 2021-05-31 | 136811 |
| APO-QUETIAPINE | 100MG | TABLET | Resolved | 2020-11-19 | 2020-12-17 | 128618 |
| APO-QUETIAPINE | 200MG | TABLET | Resolved | 2017-05-04 | 2017-07-04 | 8883 |
| APO-QUETIAPINE | 300MG | TABLET | Resolved | 2018-07-31 | 2018-09-28 | 56989 |
| APO-QUETIAPINE | 100MG | TABLET | Resolved | 2019-12-05 | 2019-12-09 | 100317 |
| APO-QUETIAPINE | 25MG | TABLET | Resolved | 2018-12-27 | 2020-10-24 | 70537 |
| APO-QUETIAPINE | 200MG | TABLET | Resolved | 2018-02-13 | 2018-04-18 | 39669 |
| APO-QUETIAPINE | 300MG | TABLET | Resolved | 2018-02-01 | 2018-04-24 | 37980 |
| APO-QUETIAPINE | 25MG | TABLET | Resolved | 2018-02-01 | 2018-04-17 | 37977 |
| APO-QUETIAPINE | 100MG | TABLET | Resolved | 2018-02-01 | 2018-04-15 | 37974 |
| APO-QUETIAPINE FUMARATE | 200MG | TABLET (IMMEDIATE RELEASE) | Actual shortage | 2024-01-19 | 2024-09-05 | 216705 |
| APO-QUETIAPINE FUMARATE | 25MG | TABLET (IMMEDIATE RELEASE) | Actual shortage | 2024-01-19 | 2024-02-23 | 216699 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
| APO-FENTANYL MATRIX | 75MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60497 |
| APO-FENTANYL MATRIX | 100MCG | PATCH | Discontinued | 2018-02-23 | 2018-12-28 | 40741 |
| APO-FENTANYL MATRIX | 25MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60489 |
| APO-FLUNISOLIDE NASAL SPRAY | 0.25MG | METERED-DOSE PUMP | Discontinued | 2018-02-26 | 2018-02-26 | 40965 |
| APO-FLUVOXAMINE TABLETS | 50MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4716 |
| APO-FLUVOXAMINE TABLETS | 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4713 |
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2019-01-02 | 2019-01-02 | 70815 |
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2018-02-26 | 2018-02-26 | 40997 |
| APO-GEMFIBROZIL | 600MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4927 |
| APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 | ||
| APO-GEMFIBROZIL CAP 300MG USP | 300MG | CAPSULE | Discontinued | 2017-03-31 | 2018-12-07 | 4920 |
| APO-GLICLAZIDE | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60512 |
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94446 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94452 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94449 | ||
| APO-HALOPERIDOL TAB 2MG | 2MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1084 |
| APO-HALOPERIDOL TAB 5MG | 5MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1087 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |